Marijuana Rescheduled - Effects on Medicinal Marijuana
As of August 12, 2026, federal medical marijuana law has changed significantly. The key point is that federal law now recognizes a limited Schedule III medical-marijuana pathway—but marijuana has not been federally legalized across the board.
State-licensed medical marijuana is now Schedule III
Effective April 2026, the Attorney General and DEA placed the following in Schedule III:
- FDA-approved products containing marijuana; and
- Marijuana, extracts, and naturally derived delta-9 THC subject to a qualifying state medical-marijuana license.
The new regulations appear in 21 C.F.R. §§ 1301.13 and 1308.13. Federal Register final rule, 91 Fed. Reg. 22714; current Schedule III regulation.
Under the rule:
- State-licensed medical cultivators, distributors, and dispensaries may obtain expedited DEA registration.
- Registered dispensaries may dispense marijuana to people authorized under state medical-marijuana law.
- A state medical-marijuana certification can substitute for a traditional prescription if it contains the required patient and practitioner information.
- A timely applicant may operate under transitional rules while DEA reviews its registration.
However, a state license alone does not indefinitely replace DEA registration.
Marijuana Rescheduled-Effects on Recreational Marijuana
This will make it easier for research and academic studies. Go to lastchanceasylum.com for all the current cannabis research. And find more stories about legalization efforts at mediweedseed.com.